Introduction {#s0005}
============

Eukaryotic translation initiation factor 5A (eIF5A) is a polyamine-dependent protein present in all eukaryotic cells [@b0005]. The precursor eIF5A undergoes a specific spermidine-dependent post-translational modification known as hypusination for eIF5A activation [@b0010]. During hypusination, a unique amino acid, Nε-(4-aminobutyl-2-hydroxyl) lysine, called hypusine, is generated by transferring the aminobutyl moiety of spermidine to a specific lysine residue in precursor eIF5A [@b0010]. Both the lysine residue and the flanking residues are conserved among eukaryotes [@b0015]. Hypusine is exclusively synthesized in precursor eIF-5A [@b0015]. Besides hypusination, eIF5A proteins are phosphorylated in *Saccharomyces cerevisiae* (eIF5Ab) [@b0020; @b0025] and maize (ZmeIF5A). The phosphorylation in ZmeIF5A occurs at serine residue 2 (S2) [@b0030]. Interestingly, eIF5A is represented by more than one isoforms in *Plasmodium falciparum*, presumably due to post-translational modifications [@b0035]. Expression of two eIF5A isoforms was decreased modestly during schizont development, while expression of another isoform with a considerably more acidic isoelectric point (pI) was increased 15-fold and demonstrated a significant fold change during the proteomic analysis of *P. falciparum* at various developmental stages [@b0035].

eIF5A from *Trichomonas vaginalis* (TveIF5A) is of archaebacterial origin [@b0040]. T. vaginalis is the protozoan parasite responsible for trichomonosis, which is the most common sexually transmitted infection. Trichomonosis is associated with an increased risk of human immunodeficiency virus (HIV) infection [@b0045], pelvic inflammatory disease [@b0050] and adverse pregnancy outcomes [@b0055]. Our previous studies reported that two spots with different isoelectric points (pI) (5.2 and 5.5) were detected in the T. vaginalis protein extracts. These two spots corresponded to the precursor (pI 5.2) and mature TveIF5A (pI 5.5), respectively [@b0040], and the mature isoform contains the hypusine residue [@b0060]. Interestingly, when putrescine biosynthesis was inhibited in *T. vaginalis* using 1,4-diamino-2-butanone (DAB) and the parasites were then transferred to a medium containing exogenous putrescine, a new TveIF5A spot with a pI of 5.3 was observed [@b0060]. According to sequencing analysis, these three isoforms shared identical primary structures; however, the precursor and intermediate isoforms were 19 kDa, while the mature isoform was 20 kDa, which is phosphorylated and glycosylated [@b0060]. Moreover, in silico analyses of the precursor isoform indicated that serine residues S3, S21, S83 and S153, threonine (T) residues T78 and T114, and tyrosine (Y) residues Y37 and Y96 are potential phosphorylation sites [@b0060]. In this study, we went further to identify the phosphorylated residues in TveIF5A using LC--MS/MS. We found that mature TveIF5A contains four phosphorylated residues, S3, T55, T78 and T82; among which S3 and T82 were also phosphorylated in the intermediary isoforms, whereas no phosphorylated residues were identified in the precursor TveIF5A.

Results {#s0010}
=======

*T. vaginalis* was grown in TYM-serum medium (control) or transferred into a medium containing exogenous putrescine after DAB treatment (DAB-treated). The extracted proteome was subjected to 2D gel separation and an identical gel was immunoblotted for the identification of the specific spots immunorecognized by the anti-TveIF5A antibodies. In this report, we focused on the 25--15 kDa region to identify phosphorylation sites in the three TveIF5A isoforms ([Figure 1](#f0005){ref-type="fig"}). For the parasites grown in the control medium, spots that were immunorecognized by the anti-peptide TveIF5A antibody corresponded to the precursor and mature TveIF5A isoforms with pIs of 5.2 and 5.5, respectively ([Figure 1](#f0005){ref-type="fig"}A). As expected, for the DAB-treated parasites that were then transferred into medium containing exogenous putrescine, the intermediary TveIF5A isoform was observed with a pI of 5.3 ([Figure 1](#f0005){ref-type="fig"}B). These three spots were excised from the gels and digested with trypsin to identify the protein and its possible phosphorylated residues by MS/MS analysis. According to the MS/MS identification, all the three isoforms, with pIs of 5.5, 5.3 and 5.2, respectively, corresponded to TveIF5A ([Table S1](#s0085){ref-type="sec"}). According to previous reports, the pI 5.5 isoform corresponds to mature TveIF5A, whereas the pI 5.3 and 5.2 isoforms correspond to the intermediary and precursor TveIF5A, respectively.

The MS/MS data were analyzed to identify modifications such as phosphorylated residues. We manually validated the peptides to identify the phosphorylated residues. [Figure 2](#f0010){ref-type="fig"} shows the phospho-site assignment for one of the phosphorylated peptides as an example. The peptide (SSAEEEVHHDLEIQEVDAGSQEK) found in the mature (pI 5.5) ([Figure 2](#f0010){ref-type="fig"}A) and intermediary (pI 5.3) ([Figure 2](#f0010){ref-type="fig"}B) TveIF5A had a monoisotopic mass of 3107.3357 and the S2 residue of this peptide represented a phosphorylated residue ([Table 1](#t0005){ref-type="table"}). Peptide MSSAEEEVHHDLEIQEVDAGSQEK was identified for the precursor TveIF5A (pI 5.2); however, no phosphorylated residues were revealed ([Figure 2](#f0010){ref-type="fig"}C).

The phosphorylation sites were identified by manual validation of the phosphorylated peptides ([Tables 1](#t0005){ref-type="table"} and [S2](#s0085){ref-type="sec"}) using Mascot analysis as described in Material and Methods section. The mature isoform (pI 5.5) contains four phosphorylated residues, S3, T55, T78 and T82, whereas the intermediary isoform (pI 5.3) contains two phosphorylated residues at S3 and T82 ([Table 1](#t0005){ref-type="table"}). No phosphorylated residues were observed in the precursor TveIF5A (pI 5.2).

The position of the phosphorylated residues in the primary sequence of TveIF5A is shown in [Figure 3](#f0015){ref-type="fig"}**A**. Multiple sequence alignment analysis indicated that T55 is highly conserved in all the species detected, while S3 and T78 are replaced with acidic residues D or E in most of the remaining species and T82 often is replaced with S, a residue potentially undergoing phosphorylation. K57, the residue for hypusination in TveIF5A [@b0060], and the flanking sequences are highly conserved across all species examined ([Figure S1](#s0085){ref-type="sec"}). TveIF5A share 37% identity with eIF5A from *Leishmania mexicana*. We thus generated a 3D model of TveIF5A using eIF5A from *L. mexicana* (PDB: [1XTD](pdb:1XTD){#ir0005}) [@b0065] as the template. According to the 3D model, the phosphorylated residues T55 and T82 are near K57 ([Figure 3](#f0015){ref-type="fig"}**B**).

Several eukaryotic translation initiation factors are reported to be phosphorylated by casein kinase 2 (CK2). For example, S2 that is highly conserved in plants and protozoan parasites ([Figure S1](#s0085){ref-type="sec"}) is phosphorylated in most plant eIF5A proteins that have been examined so far [@b0070; @b0075; @b0080] . In most plant eIF5As, the phosphorylation of S2 is performed by a protein that belongs to the family of CK2 kinases [@b0085]. Given the involvement of CK2 in the phosphorylation of plant eIF5A, we searched for the homologue of plant CK2 in the *T. vaginalis* genome. Our results showed that locus TVAG_064190 contains a 1023 bp open reading frame (ORF) potentially encoding a protein of the CK2 kinase family (*tvck2*) ([Figure S2A](#s0085){ref-type="sec"}). Protein sequence alignment analysis showed that the TvCK2 residues 50--333 correspond to the protein kinase domain containing the ATP-binding region signature (56-VGTGKYSDVFtAykgdtk\...VAIK-77) and the S/T protein kinase active site signature (161-ImHrDVKplNILF-173) ([Figure S2B](#s0085){ref-type="sec"}). In addition, gene expression of *tvck2* was detected in the CNCD147 isolate of *T. vaginalis* by using RT-PCR ([Figure S2C](#s0085){ref-type="sec"}).

Discussion {#s0015}
==========

The highly conserved eukaryotic translation initiation factor 5A (eIF5A) is involved in a broad spectrum of cellular functions. In *Arabidopsis*, three eIF5A isoforms have been identified including AteIF5A1, AteIF5A2 and AteIF5A3, which play different roles in various biological processes [@b0070; @b0075; @b0080]. For example, AteIF5A1 is involved in xylem formation, whereas AteIF5A2 participates in cell division, growth and death caused by pathogen infection and AteIF5A3 responds to osmotic and nutrient stresses [@b0070; @b0075; @b0080].

Three TveIF5A isoforms have been reported with the mature isoform phosphorylated [@b0060]. Using LC--MS/MS, we demonstrated in this study that the precursor TveIF5A is not phosphorylated; the intermediate isoform is phosphorylated at S3 and T82 and the mature isoform is phosphorylated at S3, T55, T78 and T82. These results are in agreement with our previous *in silico* analyses [@b0060].

Despite the absence in mammalian eIF5A [@b0090], N-terminal S2 is highly conserved in plants and protozoan parasites examined, which could potentially be phosphorylated by CK2 [@b0095]. In maize, S2 phosphorylation of eIF5A plays a unique role in regulating the intracellular localization of eIF5A and the nuclear export of mRNAs it binds to [@b0090]. However, no phosphorylation was observed at S2 in TveIF5A; instead, phosphorylation was detected at S3 in the mature and intermediary TveIF5A isoforms. Our preliminary data suggest that TveIF5A might bind to certain mRNAs that possess eIF5A consensus-binding elements (unpublished data), suggesting that phosphorylation of mature TveIF5A might participate in specific regulation of this protein in *T. vaginalis* as well. Interestingly, S3 is replaced with acidic residues D/E in most other species. Similar replacement is also observed for T78. TveIF5A is highly similar to its counterparts found in other protozoa, plant and human. According to our previous phylogenetic analyses, TveIF5A is more closely grouped with the bacterial elongation factor P [@b0040]. These suggest an early evolution of TveIF5A and high conservation in the evolutionary scale.

Phosphorylated residues T55 and T82 are located near K57, the site for hypusination in TveIF5A. In particular, the conserved T55 is located in the same loop with K57. In higher eukaryotes, the positively charged hypusine residue in eIF5A facilitates its bind to exportin 4 (Exp4), enhancing the nuclear export of eIF5A [@b0100]. On the other hand, the negative charge in the phosphorylated residues may prevent the interaction of eIF5A with its nuclear receptor, causing an accumulation of eIF5A in the nucleus [@b0090]. Interestingly, human CK2 possesses a nuclear localization signal [@b0105], which might phosphorylate and retain eIF5A in the nucleus [@b0090]. A recent study showed that the phosphorylated proteins might have a crucial function in the morphological transformation of *T. vaginalis* from trophozoite to amoeboid or pseudocyst [@b0110]. Our preliminary study suggests that hypusination may be involved in stabilizing mRNA coding for these proteins (unpublished data). Until now, it remains obscure whether there is a link between hypusination and phosphorylation or whether their proximity has a biological significance. Further studies are needed to elucidate the specific function of mature TveIF5A, the potential involvement of phosphorylation and its association with hypusination in the role of this protein.

CK2 is a ubiquitously expressed serine/threonine protein kinase present in all eukaryotes [@b0115]. Several eukaryotic translation initiation factors are reported to be phosphorylated by CK2. For example, CK2 phosphorylates S2 in eIF2β from human [@b0120], S318 in eIF2a, T52 and T85 in eIF2b, and S209, T240 and S451 in eIF5 from wheat [@b0125].

Our data also show that *T. vaginalis* contains an ORF coding for TvCK2. It was reported that the consensus substrate sequence for CK2 is S/T-x-x-E/D/pS [@b0085]. Interestingly this consensus sequence was found in the phosphorylated S3 residue (M**S**SAE...) and in the phosphorylated T82 (..**T**SHE..) in TveIF5A. CK2β is autophosphorylated [@b0130] at S2 (M**[S]{.ul}**SSEEV...) and S3 (MS**[S]{.ul}**SEEV...) [@b0085; @b0130]. Interestingly, TveIF5A also contains S2 and S3 (M**[SS]{.ul}**AEEE...) in its N-terminal domain, suggesting that phosphorylation at S3 of TveIF5A revealed by MS/MS analysis might be performed by CK2 present in *T. vaginalis*. Thus, TvCK2 might phosphorylate the S3 or T82 residues of TveIF5A. However, we cannot rule out the possibility that other kinases are involved in phosphorylation of TveIF5A, since there are ∼880 putative kinase genes in *T. vaginalis* genome, which encode distinct protein kinases [@b0135].

In conclusion, LC--MS/MS analysis indicates that in *T. vaginalis*, TveIF5A precursor is a non-phosphorylated isoform and mature TveIF5A is phosphorylated at S3, T55, T78 and T82, whereas the intermediate isoform, which is found under polyamine depletion and upon restoration using exogenous putrescine, is phosphorylated at S3 and T82. The differential phosphorylation profiles may explain the different pIs of three TveIF5A isoforms. An endogenous CK2 that is expressed in *T. vaginalis* might be involved in the phosphorylation of TveIF5A.

Materials and methods {#s0020}
=====================

*T. vaginalis* culture {#s0025}
----------------------

The parasites were grown in Diamond's trypticase-yeast extract-maltose (TYM) medium supplemented with 10% heat-inactivated horse serum (TYM-serum) for 24 h at 37 °C (referred to as normal medium). The polyamine metabolism was inhibited as previously reported [@b0060]. Briefly, the parasites were grown for 24 h at 37 °C in TYM-serum medium supplemented with 20 mM 1,4-diamino-2-butanone (DAB) (Sigma Chemical, St. Louis, MO), washed with sterile phosphate-buffered saline (PBS) and transferred to TYM-serum medium supplemented with 40 mM putrescine for 30 min (Sigma) (referred to as DAB-Putrescine).

Two-dimensional gel electrophoresis (2DE) {#s0030}
-----------------------------------------

Parasites from *T. vaginalis* (1.8 × 10^8^) were collected by centrifugation at 900*g* for 5 min (4 °C), washed three times with PBS (pH 7.0) and lysed in rehydration solution containing 7 M urea, 4% CHAPS, 70 mM DTT, 2% IPG buffer (pH 4--7) and trace bromophenol blue (Bio-Rad) as previously reported [@b0140]. For the first dimension, 70 μg of protein was applied to an IPG strip (17 cm, pH 4--7 linear; Bio-Rad). All isoelectric focusing took place on a Protean IEF system (Bio-Rad). Before the second dimension, the proteins were reduced (10 mg/ml DTT) and alkylated (25 mg/ml iodoacetamide) step-wise. Equilibrated IPG strips were separated on 15% SDS--PAGE gels and were then stained using SYPRO® Ruby Protein Gel stain (Invitrogen) following procedures described by the manufacturer or transferred onto nitrocellulose membranes for 2DE Western blotting. Finally, the stained gels were documented using a Gel Doc EQ (Bio-Rad) system. Image analysis was performed using the PDQuest software (Bio-Rad).

Western blotting {#s0035}
----------------

The 2DE separated proteins were transferred onto nitrocellulose membranes and blocked with 0.5% skim milk in 1 × PBS with 0.05% Tween-20 (PBS-Tween) for 18 h at 4 °C. The membranes were incubated with anti- TveIF5A mouse serum (1:1000 dilution) [@b0040] for 18 h at 4 °C, washed five times with 1 × PBS with 0.1% Tween-20 (PBST), incubated with a peroxidase-conjugated secondary antibody (1:3000 dilution; Bio-Rad) for 2 h at 25 °C, and developed by chemiluminescence using an enhanced chemiluminescence ECL Plus Western blotting detection system (GE Healthcare) according to the manufacturer's instructions. Preimmune mouse serum (PI) was used as a negative control (1:1000 dilution).

Finally, the image analysis was performed using the pDQuest software (Bio-Rad) to match the immunorecognized spots with their corresponding protein spots in the gels. These spots were then excised from the gels and digested with trypsin for identification by mass spectrometry.

Identification of phosphorylated residues {#s0040}
-----------------------------------------

After staining the gels, the spots were excised and digested using trypsin according to a previous protocol [@b0145]. Samples were incubated for trypsin digestion overnight (37 °C), and 100 μl of extraction buffer (1:2 (vol/vol) 5% formic acid/acetonitrile) was then added to each tube. The tubes were incubated for 15 min (37 °C) in a shaker. Samples were centrifuged at 900*g* for 5 min, and the supernatant was collected in a tube and dried in a vacuum centrifuge. The samples were redissolved in 20 μl of 0.1% (vol/vol) trifluoroacetic acid in a tube, purified using C18 ZipTip pipette tips (Millipore, USA) following the manufacturer's instruction and then injected into the instrument as previously reported [@b0140].

Search parameters {#s0045}
-----------------

The default search parameters were such that a Mascot server (Matrix Science, London, UK, available at <http://www.matrixscience.com>, version 2.2; Matrixscience, London, UK) threshold score of 5% indicated that the protein identification was likely incorrect. The Mascot Distiller v2.1 was used for peak list generating software. All samples were searched with the taxonomy filter "Other Eukaryota" (379307 sequences). The database search parameters were set as follows: enzyme (trypsin with a maximum of one missed cleavages); fixed modifications (carbamidomethyl (±57.021 Da at cysteine residue)); variable modifications (deamidated (±1 Da at cysteine residue)) and methionine oxidation (±15.995 Da at methionine residue) Phospho (ST), Phospho (Y); peptide mass tolerance (±1.2 Da); fragment mass tolerance (±0.6 Da); mass tolerance for precursor ions (±100 ppm); and mass tolerance for fragment ions (±0.6 Da). The protein identification reporting criteria included at least two MS/MS spectrum matched at the 95% level of confidence (molecular weight search score ± 25) and the presence of a consecutive β and/or γ ion series of three or more amino acids. Instrument type is ESI-QUAD-LIT.

*In silico* analysis {#s0090}
--------------------

The N-terminal domains of eIF5A from different species were aligned using the Clustal W program (<http://www.ch.embnet.org/software/ClustalW.html>) using gap penalties of 10 to minimize internal gaps. The sequences of *Zea mays* ([NP_001105550.1](ncbi-p:NP_001105550.1){#ir0020}), *Oryza sativa* ([CAC84392.1](ncbi-p:CAC84392.1){#ir0025}), *Arabidopsis thaliana* ([AEE29088.1](ncbi-p:AEE29088.1){#ir0030}), *Toxoplasma gondii* ([EEB00280.1](ncbi-p:EEB00280.1){#ir0035}), *P. falciparum* ([AAM46152.1](ncbi-p:AAM46152.1){#ir0040}), *S. cerevisiae* ([AAB65008.1](ncbi-p:AAB65008.1){#ir0045}), *Schizosaccharomyces pombe* ([CAB16195.1](ncbi-p:CAB16195.1){#ir0050}), *Homo sapiens* ([NP_001961.1](ncbi-p:NP_001961.1){#ir0055}), *Mus musculus* ([CAI35154.1](ncbi-p:CAI35154.1){#ir0060}), *Drosophila melanogaster* ([NP_611878.1](ncbi-p:NP_611878.1){#ir0065}), *Entamoeba histolytica* ([XP_657397.1](ncbi-p:XP_657397.1){#ir0070}), *Leishmania infantum* ([CAB95733.1](ncbi-p:CAB95733.1){#ir0075}), and *T. vaginalis* ([ADE62353.1](ncbi-p:ADE62353.1){#ir0080}) were used for the alignment.

TveIF5A modelling {#s0055}
-----------------

The Swiss-Model Workspace (<http://swissmodel.expasy.org/>) tool was used to model TveIF5A using *L. mexicana* eIF5A (X-ray resolution: 2.70Å) (PDB ID: [1XTD](pdb:1XTD){#ir0090}) as the template. The PyMol software (DeLano Scientific LLC v0.99) was used to highlight the phosphorylation sites in TveIF5A.

Screening of databases and the sequence analysis of CK2 from ***T. vaginalis*** {#s0095}
-------------------------------------------------------------------------------

The CK2 gene sequences from several species were obtained from the GenBank database (<http://www.ncbi.nlm.nih.-gov/Genbank/>). The search for the CK2 gene in the trichDB genome database (<http://www.trichdb.org/trichdb/>) was performed using the consensus sequences of CK2 from *Leishmania major, H. sapiens, Arabidopsis thaliana* and *S. cerevisiae* as query. The deduced amino acid sequence of CK2 from *T. vaginalis* (TvCK2) was subsequently aligned using the Clustal W program (<http://www.ch.embnet.org/software/ClustalW.html>) and used to determine the percentage of identity and E values for the related proteins by BLAST (<http://www.expasy.org/tools/blast/>). The alignment with ClustalW used gap penalties of 10 to minimize internal gaps.

Amplification of ***tvck2*** from ***T. vaginalis*** {#s0100}
----------------------------------------------------

*T. vaginalis* isolate CNCD147 was collected by centrifugation at 900*g* for 5 min at 4 °C (AllegraTM X-22 Centrifuge, Beckman Coulter). The pellet was suspended in 1 ml of TRIzolR reagent (Invitrogen, Life Technologies, Carlsbad, CA). Total RNA was extracted as recommended by the manufacturer and reversely transcribed using the Superscript Reverse Transcriptase kit (Invitrogen) and the oligo-dT (dT18) (10 pmol/μl) primer. PCR amplification was performed using the primers (sense: 5′-GATC[GGATCC]{.ul}ATGTCGCGTGGAAGGGCGGTTCAAAG-3′; antisense: 5′-CTGCA[CTGCAG]{.ul}TTATGGTTCAATTTTCATGTTGCGAACAGAATCG-3′). (GenBank accession number for *tvck2* is [KC688695](ccdc:KC688695){#ir0115}).
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Supplementary Figure 2**Figure S1. Sequence alignment of eIF5A from different species** The amino acid sequences of eIF5A from various species were aligned by the Clustal W. The arrowhead indicates the S2 of the eIF5As, which is highly conserved in plant and protozoan parasite. The dashes indicate gaps introduced to maximize the alignment. The sequences included in the analysis are from *Zea mays* (maize) (NP_001105550.1), *Oryza sativa* (rice) (CAC84392.1), *Arabidopsis thaliana* (AEE29088.1), *Toxoplasma gondii* (toxoplasma) (EEB00280.1), *Plasmodium falciparum* (plasmodium) (AAM46152.1), *Saccharomyces cerevisiae* (budding yeast) (AAB65008.1), *Schizosaccharomyces pombe* (fission yeast) (CAB16195.1), *Homo sapiens* (human) (NP_001961.1), *Mus musculus* (CAI35154.1), *Drosophila melanogaster* (fly) (NP_611878.1), *Entamoeba histolytica* (amoeba) (XP_657397.1), *Leishmania infantum* (leishmania) (CAB95733.1) and *Trichomonas vaginalis* (trichomona) (ADE62353.1). The phosphorylated residues found in TveIF5A are underlined.Supplementary Figure 3**Figure S2. Gene expression and protein sequence analysis of TvCK2 A.** Genomic organization of the locus TVAG_064190, which contains a 1320 bp ORF coding for a protein kinase (TvCK2) in *T. vaginalis*. A gene that encodes a putative protein is located upstream and a conserved hypothetical protein is downstream (blocks) of TvCK2. **B.** The amino acid sequence of CK2 from *T. vaginalis* was aligned with its counterparts from other species using the ClustalW program. The lines indicate signature region for the ATP-binding region (residues 56-77 in TvCK2) and the S/T protein kinase active site (residues 161-173 in TvCK2). The asterisk indicates the proton acceptor (D165 in TvCK2). Gaps are introduced to maximize the alignment. The nuclear localization signal (NLS) from human CK2 (K74-K77) was indicated with "NLS" above and presented in larger font size. The CK2 sequences are from *Leishmania major* (XP_001687095.1), *Homo sapiens* (ABC86794.1), *Babesia bovis* (EDO06573.1), *Bos taurus* (NP_001039919.1), *Mus musculus* (AAH57862.1), *Rattus norvegicus* (AAH78807.2), *Danio rerio* (AAB34249.1), *Drosophila melanogaster* (NP_730774.1), *Oryza sativa* (BAB21591.1), *Nicotiana tabacum* (ACB56636.1), *Zea mays* (NP_001105486.1), *Arabidopsis thaliana* (AEC10455.1), *Candida orthopsilosis* (CCG21924.1) and *Saccharomyces cerevisiae* (EDN63928.1). **C.** PCR amplification of *tvck2*. cDNA from *T. vaginalis* isolate CNCD147 was used as template by PCR to amplify a 1032-bp fragment (lane 1). PCR reaction with no cDNA template served as the negative control (line 2). The arrowhead indicates the amplicon obtained. The identity of the amplicon was verified by sequencing and named as *tvck2*. The sequence of *tvck2* was submitted to GenBank (KC688695).Supplementary data 1Table S1. MS/MS fragmentation of TveIF5A isoforms.Supplementary data 2Table S2. Phosphorylated residues in TveIF5A.

This work was supported by grants from Consejo Nacional de Ciencia y Tecnología (CONACyT; Grant No. 83808) Mexico awarded to MEAS. and Instituto de Ciencia y Tecnología del Distrito Federal (ICyTDF; Grant No. 221/2011, 328/2011, 18/2011 and 321/2009). We acknowledge Brenda Herrera Villalobos and Laura Isabel Vazquez Carrillo from the Autonomous University of Mexico City UACM for their technical assistance.

Peer review under responsibility of Beijing Institute of Genomics, Chinese Academy of Sciences and Genetics Society of China.

![**Identification of the three TveIF5A isoforms***Trichomonas vaginalis* was grown under normal conditions (**A**) or treated with DAB and then cultured in a medium containing exogenous putrescine for 30 min (**B**). Total proteins were extracted and separated on 15% polyacrylamide 2DE gel. The gel was stained with Sypro-Ruby. Shown here are partial gels containing small proteins (15--25 kDa) including TveIF5A isoforms (boxed). The pI of each TveIF5A spot is indicated at the bottom. Experiments were performed at least in triplicate with identical results.](gr1){#f0005}

![**Phospho-site assignment and manual validation** The peptides SSAEEEVHHDLEIQEVDAGSQEK in the mature (**A**) and intermediary (**B**) TveIF5A and MSSAEEEVHHDLEIQEVDAGSQEK in the precursor TveIF5A (**C**) were obtained by Mascot analysis and subjected to manual validation for the phosphorylation sites. The S2 in peptide SSAEEEVHHDLEIQEVDAGSQEK from the mature and intermediary TveIF5A isoforms produced a positive signal for phosphorylation, whereas, the corresponding residue is not phosphorylated in the precursor.](gr2){#f0010}

![**TveIF5A phosphorylation sites A.** Shown is the location of the phosphorylation sites identified using MS/MS analysis in the primary sequence of TveIF5A. Phosphorylated residues found in the mature isoform are indicated by ^∗^ above, whereas phosphorylated residues found in the intermediary isoform are indicated by + above. **B.** TveIF5A model base on the template [1XTD](pdb:1XTD){#ir0125} from *Leishmania mexicana* eIF5A. The phosphorylated (T55, T78 and T82) residues and the hypusine-containing residue (K57) are indicated in balls.](gr3){#f0015}

###### 

Phosphorylated residues identified in the TveIF5A isoforms

  **Isoform**    **pI**                               **MS/MS fragmentation peptide**      **Monoisotopic mass of the neutral peptide (calc)**   **Phosphorylated residue and its position in the fragmentation peptide**
  -------------- ------------------------------------ ------------------------------------ ----------------------------------------------------- --------------------------------------------------------------------------
  Mature         5.5                                  YE**[T]{.ul}**HLPTSHEIEVPFVDR        2167.9827                                             T3
                 RYETHLP**[T]{.ul}**SHEIEVPFVDR       2338.0995                            T8                                                    
                 **[T]{.ul}**GKHGHAKAGIAGTDLFTGR      2354.2009                            T1                                                    
                 S**[S]{.ul}**AEEEVHHDLEIQEVDAGSQEK   3107.3357                            S2                                                    
                                                                                                                                                 
  Intermediary   5.3                                  S**[S]{.ul}**AEEEVHHDLEIQEVDAGSQEK   3107.3357                                             S2
                 YETHLP**[T]{.ul}**SHEIEVPFVDR        2167.9827                            T7                                                    

*Note:* The variable modification for phospho (S/T) is neutral loss of 97.9769.

[^1]: Deceased.
